Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

When President Donald Trump hits "post" on Truth Social, Wall Street braces for impact. What Happened: Various stock prices — ...

President Trump has taken a firm stance on reducing American drug prices, sending letters to 17 major pharmaceutical ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

On the company’s Q2 earning call, Pfizer noted that the company’s guidance “absorbs the impact of the currently imposed tariffs from China, Canada and Mexico as well as pote ...

President Trump’s latest tariff threat has targeted a sector that’s already hobbled.

Trump has said that tariffs on pharmaceutical imports could reach 250%, the steepest rate he has proposed for the sector. Trump, who in July threatened 200% duties, wants to motivate drug companies to ...

Pfizer CEO Albert Bourla said his company is in “very active discussions” over Trump’s request concerning most-favoured-nation pricing, according to news website FiercePharma. Bourla said he had ...

The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...

Pharmaceuticals account for the bulk of Irish exports to the US and any change, or even uncertainty, on tariffs poses major ...